These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998 [TBL] [Abstract][Full Text] [Related]
10. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766 [TBL] [Abstract][Full Text] [Related]
11. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)]. Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811 [TBL] [Abstract][Full Text] [Related]
12. Organ preservation surgery for laryngeal cancer. Tufano RP; Stafford EM Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956 [TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect? Pfister DG; Ridge JA J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409 [No Abstract] [Full Text] [Related]
15. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma]. Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756 [TBL] [Abstract][Full Text] [Related]
16. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415 [TBL] [Abstract][Full Text] [Related]
18. Commentary: phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy--intergroup trial R91-11. Wolf GT J Clin Oncol; 2001 Sep; 19(18 Suppl):28S-31S. PubMed ID: 11560968 [No Abstract] [Full Text] [Related]
19. [In patients with cancer of the larynx, chemoradiotherapy with cisplatin is superior to neoadjuvant chemotherapy followed by radiotherapy and to exclusive radiotherapy]. Racadot S; Mazeron JJ Bull Cancer; 2004 Mar; 91(3):211-2. PubMed ID: 15171045 [No Abstract] [Full Text] [Related]
20. Searching for less toxic larynx preservation: a need for common definitions and metrics. Forastiere AA; Trotti AM J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460 [No Abstract] [Full Text] [Related] [Next] [New Search]